CS logo
small CS logo
University of Washington AIDS CRS (1401)

Seattle, Washington, United States

About University of Washington AIDS CRS (1401)


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at University of Washington AIDS CRS (1401)


During the past decade, University of Washington AIDS CRS (1401) conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 10 clinical trials were completed, i.e. on average, 142.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "University of Washington AIDS CRS (1401)" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 17 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Adult AIDS Clinical Trials Group" with 1 trials as a collaborator, "Exegi Pharma, LLC" with 1 trials as a collaborator and "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

Clinical Trials Conditions at University of Washington AIDS CRS (1401)


According to Clinical.Site data, the most researched conditions in "University of Washington AIDS CRS (1401)" are "HIV-1 Infection" (11 trials), "HIV Infections" (4 trials), "HIV Infection" (2 trials) and "Hepatitis C Infection" (1 trials). Many other conditions were trialed in "University of Washington AIDS CRS (1401)" in a lesser frequency.

Clinical Trials Intervention Types at University of Washington AIDS CRS (1401)


Most popular intervention types in "University of Washington AIDS CRS (1401)" are "Drug" (16 trials). Other intervention types were less common.
The name of intervention was led by "Ritonavir" (3 trials), "Atazanavir" (2 trials), "Darunavir" (2 trials), "Abacavir/Lamivudine" (1 trials) and "Abacavir/Lamivudine placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at University of Washington AIDS CRS (1401)


The vast majority of trials in "University of Washington AIDS CRS (1401)" are 16 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at University of Washington AIDS CRS (1401)


Currently, there are NaN active trials in "University of Washington AIDS CRS (1401)". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in University of Washington AIDS CRS (1401), undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in University of Washington AIDS CRS (1401), 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".